BC
TRAW icon

Boxer Capital’s Traws Pharma TRAW Stock Holding History

Boxer Capital’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-43
Closed -$92K – 28
2017
Q3 		$92K Sell
43
-11
-20% -$114K 0.02% 30
2017
Q2 		$654K Sell
54
-2
-4% -$24.8K 0.16% 26
2017
Q1 		$962K Hold
56
– – 0.21% 28
2016
Q4 		$718K Hold
56
– – 0.28% 25
2016
Q3 		$838K Buy
+56
New +$1.14M 0.38% 25

Other funds holding TRAW

TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital's TRAW Position: Q4 2017 in Review

Boxer Capital sold out of Traws Pharma (TRAW) in Q4 2017, closing a stake of 43 shares — an estimated $92K sold.

Boxer Capital first reported a position in TRAW in Q3 2016 and held it in 5 quarters. The position peaked at $962K in Q1 2017. 9 funds tracked by Wall St. Rank hold TRAW as of Q4 2017.

  • Boxer Capital reported no remaining Traws Pharma position as of Q4 2017 after selling out during the quarter.
  • Boxer Capital sold 43 Traws Pharma shares in Q4 2017, an estimated $92K.
  • Boxer Capital first reported a position in Traws Pharma in Q3 2016 and held it in 5 quarters.
  • Boxer Capital's Traws Pharma position peaked at $962K in Q1 2017.
  • 9 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2017.

Based on Boxer Capital's 13F filing for Q4 2017, filed 14 Feb 2018.